¿Afecta la obesidad a la respuesta al tratamiento con secukinumab y a su supervivencia en la espondilitis anquilosante? Datos reales del Registro TURKBIO
Mod Rheumatol.2023 doi 10.1093/mr/road061 Epub ahead of print
This observational study suggested that obesity did not affect secukinumab treatment response and drug retention in AS patients.